210 related articles for article (PubMed ID: 28733204)
1. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Lin YC; Chen WJ; Huang CY; Shiue HS; Pu YS; Chen CH; Su CT
Toxicol Appl Pharmacol; 2017 Oct; 332():1-7. PubMed ID: 28733204
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
[TBL] [Abstract][Full Text] [Related]
3. Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure.
Huang CY; Su CT; Chung CJ; Pu YS; Chu JS; Yang HY; Wu CC; Hsueh YM
Toxicol Appl Pharmacol; 2012 Aug; 262(3):349-54. PubMed ID: 22659136
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma.
Chung CJ; Bao BY; Lin YC; Huang YL; Shiue HS; Ao PL; Pu YS; Huang CY; Hsueh YM
Sci Rep; 2020 Apr; 10(1):6640. PubMed ID: 32313131
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 Polymorphisms and Urinary 8-Hydroxydeoxyguanine Levels Are Associated with Urothelial Carcinoma.
Chiang CI; Huang YL; Huang CY; Shiue HS; Chen WJ; Pu YS; Lin YC; Hsueh YM
PLoS One; 2015; 10(5):e0124066. PubMed ID: 25938407
[TBL] [Abstract][Full Text] [Related]
7. Association of XRCC1 polymorphisms with arsenic methylation.
Fujihara J; Yasuda T; Iwata H; Tanabe S; Takeshita H
Arch Toxicol; 2016 Apr; 90(4):1009-12. PubMed ID: 25731970
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between polymorphisms of X-ray repair cross-complementing group 1 gene Arg194Trp, Arg399Gln and susceptibility of breast cancer].
Qian Y; Zhang JP; Dong J; Wang FR; Lin YD; Xu M; Wu LL; Shi P; Shen HB
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):242-6. PubMed ID: 20450747
[TBL] [Abstract][Full Text] [Related]
9. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.
Yang SM; Huang CY; Shiue HS; Huang SP; Pu YS; Chen WJ; Lin YC; Hsueh YM
PLoS One; 2015; 10(12):e0145410. PubMed ID: 26701102
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
[TBL] [Abstract][Full Text] [Related]
11. Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study.
Datkhile KD; Gudur RA; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3065-3075. PubMed ID: 37774058
[TBL] [Abstract][Full Text] [Related]
12. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk.
Guo LY; Jin XP; Niu W; Li XF; Liu BH; Wang YL
Asian Pac J Cancer Prev; 2012; 13(9):4423-6. PubMed ID: 23167354
[TBL] [Abstract][Full Text] [Related]
13. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
14. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
15. [Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer].
Xu C; Wang X; Zhang Y; Li L
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):912-7. PubMed ID: 22152690
[TBL] [Abstract][Full Text] [Related]
16. [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma].
Zhu QX; Bian JC; Shen Q; Jiang F; Tang HW; Zhang HW; Wu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):702-5. PubMed ID: 15555397
[TBL] [Abstract][Full Text] [Related]
17. The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area.
Huang CY; Su CT; Chu JS; Huang SP; Pu YS; Yang HY; Chung CJ; Wu CC; Hsueh YM
Toxicol Appl Pharmacol; 2011 Dec; 257(3):349-55. PubMed ID: 21982800
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
19. XRCC1 Arg194Trp polymorphism and risk of chronic obstructive pulmonary disease.
Xie J; Yang S; Xu Y; Zhang Z
J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):551-6. PubMed ID: 19821085
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
